Medicine and Dentistry
Angiogenesis
22%
Angiogenesis Inhibitor
5%
Antiangiogenic
8%
Bevacizumab
12%
Biological Marker
100%
Blood Oxygenation
6%
Brain Tumor
11%
Cancer Model
6%
Cancer Research
6%
Cediranib
7%
Chemoradiotherapy
7%
Colorectal Cancer
9%
Dynamic Contrast-Enhanced Imaging
6%
Dynamic Contrast-Enhanced MRI
43%
Ganglioglioma
7%
Glioblastoma
6%
Hypoxia
47%
Imaging Technique
13%
Liver Metastasis
6%
Lung Cancer
15%
Magnetic Resonance Imaging
91%
Magnetic Resonance Imaging
9%
Malignant Neoplasm
9%
Microvessel
9%
Molecular Imaging
5%
Neoplasm
88%
Non Small Cell Lung Cancer
7%
Perfusion Weighted Imaging
6%
Personalized Medicine
7%
Pharmacodynamics
8%
Positron Emission Tomography
10%
Positron Emission Tomography
7%
Prostate Cancer
5%
Quantitative Imaging
6%
Radiation Therapy
32%
Radiomics
14%
Reproducibility
10%
Scintigraphy
12%
Solid Malignant Neoplasm
10%
Treatment Response
9%
Tumor Angiogenesis
9%
Tumor Hypoxia
24%
Tumour Heterogeneity
5%
U87
8%
Vascular Tissue Neoplasm
6%
Vascular-Targeting Agent
6%
Vasculotropin
6%
Vasculotropin Inhibitor
9%
Volunteer
10%
Xenograft
22%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
12%
Biological Marker
53%
Cediranib
12%
Chemotherapy
9%
Colorectal Cancer
12%
Hypoxia
15%
Liver Metastasis
6%
Neoplasm
58%
Non Small Cell Lung Cancer
9%
Pharmacodynamics
13%
Solid Malignant Neoplasm
9%
Therapeutic Effect
6%
Tracer
5%
Vasculotropin
6%
Vasculotropin Inhibitor
10%